1. 1-24 of 354 1 2 3 4 ... 13 14 15 »
    1. Kaleido Biosciences Appoints Anne Prener, M.D., Ph.D., to its Board of Directors

      Kaleido Biosciences Appoints Anne Prener, M.D., Ph.D., to its Board of Directors

      LEXINGTON, Mass., April 03, 2020 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and improve human health, today announced the appointment of Anne Prener, M.D., Ph.D., to its Board of Directors...

      Read Full Article
    2. Harpoon Therapeutics Appoints Two New Members to Its Board of Directors

      Harpoon Therapeutics Appoints Two New Members to Its Board of Directors

      SOUTH SAN FRANCISCO, Calif., April 01, 2020 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced that it has appointed Andrew R. Robbins and Joseph S. Bailes, M.D., to its Board of Directors...

      Read Full Article
    3. Rockwell Medical, Inc. Appoints Pharmaceutical Industry Leader Robert S. Radie to Board of Directors

      Rockwell Medical, Inc. Appoints Pharmaceutical Industry Leader Robert S. Radie to Board of Directors

      WIXOM, Mich., March 31, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, announced today the appointment of pharmaceutical industry leader Robert (“Bob”) S. Radie to its Board of Directors...

      Read Full Article
    4. NextCure Announces Appointment of Veteran Oncology Executive Garry Nicholson to its Board of Directors

      NextCure Announces Appointment of Veteran Oncology Executive Garry Nicholson to its Board of Directors

      BELTSVILLE, Md., March 30, 2020 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced the appointment of Garry Nicholson to its board of directors...

      Read Full Article
    5. 89bio Appoints Healthcare Industry Veteran Steven Altschuler, M.D., as Chairman of the Board of Directors

      89bio Appoints Healthcare Industry Veteran Steven Altschuler, M.D., as Chairman of the Board of Directors

      SAN FRANCISCO, March 25, 2020 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced the appointment of Steven Altschuler, M.D., as chairman of its board of directors...

      Read Full Article
    6. TRACON Pharmaceuticals Announces Appointment of Saundra Pelletier to Board of Directors

      TRACON Pharmaceuticals Announces Appointment of Saundra Pelletier to Board of Directors

      SAN DIEGO, March 19, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing a product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., announced today the appointment of Saundra Pelletier...

      Read Full Article
    7. PayScale Announces the Appointment of Microsoft Executive Marc Brown to Their Board of Directors

      PayScale Announces the Appointment of Microsoft Executive Marc Brown to Their Board of Directors

      SEATTLE, March 18, 2020 (GLOBE NEWSWIRE) -- Today, PayScale, Inc., the world’s leading provider of cloud-based compensation software and data, announced that Microsoft Corporate Vice President, Corporate Development, Marc Brown is joining PayScale’s Board of Directors...

      Read Full Article
    8. Corcept Therapeutics Appoints Gregg Alton to Board of Directors

      Corcept Therapeutics Appoints Gregg Alton to Board of Directors

      MENLO PARK, Calif., March 12, 2020 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the stress hormone cortisol, announced today that former Gilead Sciences executive Gregg Alton has joined Corcept’s Board of Directors...

      Read Full Article
    1-24 of 354 1 2 3 4 ... 13 14 15 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content